Role of Caveolin 1 and E-Cadherin in Methotrexate Resistance in Colon Cancer Cells
Author Information
Author(s): Selga Elisabet, Morales Cristina, Noé Véronique, Peinado Miguel A, Ciudad Carlos J
Primary Institution: University of Barcelona
Hypothesis
The genetic features related to the progression pathway in colorectal cancer may condition its chemoresistance capability.
Conclusion
Caveolin 1 and E-cadherin play critical roles in cell survival and may be potential targets for therapy in methotrexate-resistant colon cancer cells.
Supporting Evidence
- Genes adjacent to the dhfr locus were overexpressed in HT29 MTX-resistant cells.
- siRNAs against caveolin 1, enolase 2, and PKCα reduced cell viability in resistant cells.
- Overexpression of E-cadherin sensitized cells toward methotrexate.
Takeaway
Some genes help cancer cells resist a drug called methotrexate, but if we change those genes, we can make the cancer cells more sensitive to the drug.
Methodology
Gene expression levels were compared between sensitive and resistant HT29 cells using microarrays, followed by validation with RT-PCR and functional assays.
Limitations
The study primarily focuses on a single cell line, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website